Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 2 days agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
Morningstar· 5 days ago- BeyondSpring Dosed First Patient of Two Phase 2 Investigator-Initiated Trials (IIT) in Plinabulin and Keytruda Combination Studies - SITC 2023 Presentation of the Phase ...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 3 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
CG follows big IPO with new results for bladder cancer drug
BioPharma Dive via Yahoo Finance· 2 days agoNewly disclosed Phase 3 results presented Friday match findings the biotech disclosed last year,...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe company’s R&D investment strategy focuses on the area of immuno-oncology and particularly the expansion of its portfolio after the success of its...
Merck reports data from Phase III gastric cancer treatment trial
Clinical Trials Arena via Yahoo Finance· 3 days agoFollowing the earlier results, the US Food and Drug Administration (FDA) gave accelerated approval...
CG sets new bar in bladder cancer, validating rare biotech IPO success story
FierceBiotech· 1 day agoCG Oncology’s late-stage bladder cancer treatment notched a complete response in roughly three-quarters of treated patients, fueling optimism that the company’s Wall Street ...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 3 days agoCancer drugs are highly prized in the industry for their pricing power, favorable reimbursement status...Strong performance of key drugs: Vyndaqel: This...
3 Investing Pros Lay Out Their Dividend Strategies—and Stock Picks
Barrons.com· 3 days agoIn February, Walmart announced a 9% dividend increase, its largest in more than a decade. Another of...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks· 2 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily ...
